HALOZYME THERAPEUTICS, INC.

HALO Nasdaq CIK: 0001159036

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation DE
Business Address 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
Mailing Address 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
Phone (858) 794-8889
Fiscal Year End 1231
EIN 880488686

Financial Overview

FY2025

$2.53B
Total Assets
$3.50
EPS

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment March 27, 2026 View on SEC
DEF 14A Definitive proxy statement March 23, 2026 View on SEC
3 Initial insider ownership report March 23, 2026 View on SEC
8-K Current report of material events March 12, 2026 View on SEC
4 Insider stock transaction report March 10, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report February 24, 2026 View on SEC
4 Insider stock transaction report February 24, 2026 View on SEC
4 Insider stock transaction report February 24, 2026 View on SEC
4 Insider stock transaction report February 24, 2026 View on SEC

Annual Reports

10-K February 17, 2026
  • Proprietary ENHANZE® technology and established partnerships drive growth and competitive advantage.
  • Strategic acquisitions, like Elektrofi, expand capabilities and partner pipelines.
View Analysis

Insider Trading

STRONG SELL 3 insiders 23 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.